| The bone marrow microenvironment at single-cell resolution AN Tikhonova, I Dolgalev, H Hu, KK Sivaraj, E Hoxha, ... Nature 569 (7755), 222-228, 2019 | 733 | 2019 |
| CXCL12-producing vascular endothelial niches control acute T cell leukemia maintenance LA Pitt, AN Tikhonova, H Hu, T Trimarchi, B King, Y Gong, ... Cancer cell 27 (6), 755-768, 2015 | 261 | 2015 |
| Direct migration of follicular melanocyte stem cells to the epidermis after wounding or UVB irradiation is dependent on Mc1r signaling WC Chou, M Takeo, P Rabbani, H Hu, W Lee, YR Chung, J Carucci, ... Nature medicine 19 (7), 924-929, 2013 | 192 | 2013 |
| In vivo epigenetic CRISPR screen identifies Asf1a as an immunotherapeutic target in Kras-mutant lung adenocarcinoma F Li, Q Huang, TA Luster, H Hu, H Zhang, WL Ng, A Khodadadi-Jamayran, ... Cancer discovery 10 (2), 270-287, 2020 | 142 | 2020 |
| Three-dimensional chromatin landscapes in T cell acute lymphoblastic leukemia A Kloetgen, P Thandapani, P Ntziachristos, Y Ghebrechristos, S Nomikou, ... Nature Genetics 52 (4), 388-400, 2020 | 141 | 2020 |
| ULK1 inhibition overcomes compromised antigen presentation and restores antitumor immunity in LKB1-mutant lung cancer J Deng, A Thennavan, I Dolgalev, T Chen, J Li, A Marzio, JT Poirier, ... Nature Cancer 2 (5), 503-514, 2021 | 76 | 2021 |
| EdnrB Governs Regenerative Response of Melanocyte Stem Cells by Crosstalk with Wnt Signaling M Takeo, W Lee, P Rabbani, Q Sun, H Hu, CH Lim, P Manga, M Ito Cell reports 15 (6), 1291-1302, 2016 | 72 | 2016 |
| Oncogenic hijacking of the stress response machinery in T cell acute lymphoblastic leukemia N Kourtis, C Lazaris, K Hockemeyer, JC Balandrán, AR Jimenez, ... Nature medicine 24 (8), 1157-1166, 2018 | 71 | 2018 |
| BRG1 loss predisposes lung cancers to replicative stress and ATR dependency M Gupta, CP Concepcion, CG Fahey, H Keshishian, A Bhutkar, ... Cancer Research 80 (18), 3841-3854, 2020 | 40 | 2020 |
| Targeting HER2 Exon 20 Insertion-Mutant Lung Adenocarcinoma with a Novel Tyrosine Kinase Inhibitor Mobocertinib H Han, S Li, T Chen, M Fitzgerald, S Liu, C Peng, KH Tang, S Cao, ... Cancer Research, 2021 | 36 | 2021 |
| In vivo epigenetic CRISPR screen identifies Asf1a as an immunotherapeutic target in Kras-mutant lung adenocarcinoma. Cancer Discov. 2020; 10 (2): 270–287. doi: 10.1158/2159-8290 F Li, Q Huang, TA Luster, H Hu, H Zhang, WL Ng, A Khodadadi-Jamayran, ... CD-19-0780.[PMC free article][PubMed][CrossRef][Google Scholar], 0 | 27 | |
| Loss of TSC1/TSC2 sensitizes immune checkpoint blockade in non–small cell lung cancer Q Huang, F Li, H Hu, Z Fang, Z Gao, G Xia, WL Ng, ... Science Advances 8 (5), eabi9533, 2022 | 21 | 2022 |
| Targeting the Atf7ip-Setdb1 complex augments antitumor immunity by boosting tumor immunogenicity H Hu, A Khodadadi-Jamayran, I Dolgalev, H Cho, S Badri, LA Chiriboga, ... Cancer Immunology Research, 2021 | 21 | 2021 |
| Epigenetic CRISPR Screens Identify Npm1 as a Therapeutic Vulnerability in Non–Small Cell Lung Cancer F Li, WL Ng, TA Luster, H Hu, VO Sviderskiy, CM Dowling, ... Cancer Research 80 (17), 3556-3567, 2020 | 21 | 2020 |
| Isolation of a buprofezin co-metabolizing strain of Pseudomonas sp. DFS35-4 and identification of the buprofezin transformation pathway K Chen, XM Liu, R Li, Y Liu, H Hu, SP Li, JD Jiang Biodegradation 22 (6), 1135-1142, 2011 | 19 | 2011 |
| Rational drug combinations with CDK4/6 inhibitors in acute lymphoblastic Leukemia KL Bride, H Hu, A Tikhonova, TJ Fuller, TL Vincent, R Shraim, MM Li, ... Haematologica, 2020 | 17 | 2020 |
| Author Correction: The bone marrow microenvironment at single-cell resolution AN Tikhonova, I Dolgalev, H Hu, KK Sivaraj, E Hoxha, ... Nature 572 (7767), E6-E6, 2019 | 9 | 2019 |
| Dynamic 3D chromosomal landscapes in acute leukemia A Kloetgen, P Thandapani, P Ntziachristos, Y Ghebrechristos, S Nomikou, ... bioRxiv, 724427, 2019 | 7 | 2019 |
| Nemvaleukin alfa, a novel engineered IL-2 fusion protein, drives antitumor immunity and inhibits tumor growth in small cell lung cancer Y Pan, Y Hao, H Han, T Chen, H Ding, KE Labbe, E Shum, K Guidry, H Hu, ... Journal for ImmunoTherapy of Cancer 10 (9), e004913, 2022 | 6 | 2022 |
| Abstract A06: The chemokine receptor CXCR4 is essential for the maintenance of T cell acute lymphoblastic leukemia. LA Pitt, AN Tikhonova, T Trimarchi, B King, H Hu, Y Gong, A Tsirigos, ... Clinical Cancer Research 21 (17 Supplement), A06-A06, 2015 | 2 | 2015 |
